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Previously, we identified the glycoprotein gO gene, UL74, as a hypervariable locus in the human cytomegalovirus (HCMV) genome
[Virology 293 (2002) 281]. Here, we analyze gO from 50 isolates from congenitally infected newborns, transplant recipients, and HIV/AIDS
patients from Italy, Australia, and UK. These are compared to four gO groups described from USA transplantation patients [J. Virol. 76
(2002) 10841]. Phylogenetic analyses identified seven genotypes. Divergence between genotypes was up to 55% and within 3%. Discrete
linkage was shown between seven hypervariable gO and gN genotypes, but not with gB. This suggests interactions, while gN and gO are
known to form complexes with distinct conserved glycoproteins gM, gH/gL, respectively, both are involved in fusogenic entry and exit.
Codon-based maximum likelihood models showed evidence for sites of positive selection. Further analyses of disease relationships should
take into account these newly defined gO/gN groups.
D 2003 Elsevier Inc. All rights reserved.Keywords: Cytomegalovirus; Glycoprotein; Strain variation; Hypervariable locus; gCIII complex; gCII complex; Positive selection; Virus infection; CMV
genotype; VaccineIntroduction
Human cytomegalovirus (HCMV) is a major opportu-
nistic infection that can lead to morbidity and death in
immunocompromised transplant and HIV/AIDS patients.
In addition, HCMV congenital disease is the primary
infectious cause of deafness or congenital abnormalities
in developed countries (Griffiths, 2002; Hsu et al., 2000;
Kovacs et al., 1999; Ljungman et al., 2002; Sissons and
Carmichael, 2002). The virus genome is one of the largest0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.09.036
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have been identified, particularly in clinical isolates as
compared to laboratory-adapted strains (Cha et al., 1996;
Prichard et al., 2001). HCMV can replicate in several cell
types in vitro and in vivo, including endothelial cells
important for intrauterine infections, as well as in associ-
ations with cardiovascular disease (Jarvis and Nelson,
2002; Maidji et al., 2002; Revello et al., 2001; Sinzger
et al., 1999). Like other herpesviruses, HCMV establishes
a latent infection after primary infections, usually during
childhood, which can reactivate later to cause disease in
immunocompromised settings. Different populations have
differing prevalences of HCMV. In Western countries, the
lower prevalence of childhood infections gives rise to
greater risk in adulthood of severe primary HCMV
infections during transplantation of infected donor organs
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women (Griffiths, 2002; Ljungman et al., 2002; Sissons
and Carmichael, 2002). With the diversity of in vivo
replication and clinical presentation, several attempts have
been made to correlate genomic variation in clinical
isolates with clinical outcome, but this has been compli-
cated by the range of diversity observed (Rasmussen et
al., 2003).
Comparisons of large-scale sequences from clinical iso-
lates to laboratory-adapted strains showed genomic rear-
rangement and deletion. This was identified in studies
comparing recent isolate Toledo to the laboratory strain
AD169 (Cha et al., 1996; Prichard et al., 2001). Here 15
kb in an inverted arrangement (ULb’) to later studies was
added to the UL section of the AD169 genome. This
encoded several proteins including hypervariable sites inFig. 1. Clustal dendrogram showing relationships between isolates gO nucleotid
sequence from the N-terminal regions from gO derived from the listed clinical is
nucleotide sequences trimmed to allow alignment of corresponding regions and
identity is indicated. The numbers in parenthesis refer to groupings derived from p
different groups with representative strains listed are AD169, 374 bp (base pairs); T
lengths were maintained within each group.UL144 (Lurain et al., 1999). This region was deleted or
altered in fibroblast cultured virus. Later studies revealed
that one or more of the genes encoded within ULb’ were
determinants of endothelial infection as well as the ability to
transfer virus to leukocytes (Hahn et al., 2003; Revello et
al., 2001). This part of the genome also encodes virus
chemokines that can have properties to chemoattract leuko-
cyte subsets possibly for virus dissemination (Akter et al.,
2003; Fleming et al., 1999; Penfold et al., 1999; Prichard et
al., 2001; Saederup and Mocarski, 2002). Variant genes
encoded at this locus presumably gave added functions for
immunomodulation or infection of specific cell populations
that were clearly not required or possibly detrimental for in
vitro infection of fibroblasts.
Interestingly, variation has also been observed in selected
glycoprotein genes outside the 15-kb region, which ise sequences obtained from HCMV wild-type clinical strains. Nucleotide
olates and laboratory strains. Clustal was used to align the sequences and
the final relationships displayed as a dendrogram. Relative percentage of
hylogenetic analyses shown in Fig. 2. Nucleotide sequence lengths from the
owne, 362 bp; 1152, 371 bp; Can4, 371 bp; M, 374 bp; ZVS, 377 bp. These
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gH were first studied, and these showed only a modest level
of variation compared to the above hypervariable sites, with
two groups for gH at 5%, and four for gB at up to 11%
(Chou, 1992a, 1992b; Chou and Dennison, 1991). Similar
results were shown for studies on the viral chemokine
receptor US28, also showing relative conservation (Arav-
Boger et al., 2002). The first locus of hypervariation in the
fibroblast-maintained viral genome was observed for glyco-
protein gN (Pignatelli et al., 2001, 2003a), with variation up
to 50% in the seven genotypes identified: gN1, gN2, gN3 (a,
b), and gN4 (a, b, c). Importantly, these genotypes did not
correlate to those identified for gB. HCMV is a large genomeFig. 2. Phylogenetic relationships between gO sequences plotted as unrooted t
sequences were analyzed using the following methods: maximum likelihood
bootstrapping shown, and distance (C) with relative distance graphed. Only the
between the genotypes; the other two methods indicate the overall relationships. Re
were used in the analyses. (D) Full-length sequences representing each group were
length gO sequences from a USA cohort (Rasmussen et al., 2002) using distance m
the designated numbers of the genotypes as noted in the text with representative
gO2b (Can4), gO3 (ZVS), and gO4 (Towne).and encodes several hypervariable loci. It is possible that a
higher threshold of variation should be considered in variant
groupings and linkage. Some indication of this complexity
was recently shown in comparisons of variant markers at
nine loci, including gH, gL, gO, and gB, but not gN, which
showed many recombinant groups and mosaicisms with little
evidence of genetic linkage (Rasmussen et al., 2003). Our
previous studies on strains Towne, AD169, and clinical
isolate PT had identified gO as an additional hypervariable
site in the fibroblast-maintained genome (Paterson et al.,
2002). We showed that the N-terminal domain harbored most
variation and this was confirmed recently in a USA study of
clinical isolates from transplantation recipients that dividedrees. Phylogenetic relationships between N-terminal encoded amino acid
(A) with branch lengths indicated, parsimony (B) with results of 100
last method represents branch lengths proportional to the relative distance
presentatives of each group showing the range of diversity as listed in Fig. 1
derived and phlyogenetic relationships investigated by comparison with full-
ethods with encoded amino acid sequence. The numbers in parenthesis give
strains as gO1a (AD169), gO1b (M or PT), gO1c (TB40E), gO2a (1152B),
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sen et al., 2002).
In this current study, we examine clinical isolates from
diverse geographic regions and different clinical settings
including congenital infections and immunocompromised
hosts. The gO variants are grouped into seven genotypes
and show for the first time genetic linkage with another
hypervariable locus, gN, which has been associated with
CMV disease (Pignatelli et al., 2003b, 2003c). The gN
groups have, like gO, been condensed to four supergroups.
Our analyses show that although gN and gO can be linked,
their supergroupings are distinct, and therefore seven inde-
pendently linked configurations need to be considered in
disease settings. Furthermore, sites for positive selection,
like gN, are also identified.Results
Sequence analyses of the gO gene, UL74, from clinical
isolates show seven divergent groups
In order to determine relationships between the isolates
based on gO variation, the variable N-terminal domain of
the HCMV gO glycoprotein gene, ORF UL74, was am-
plified by polymerase chain reaction (PCR) followed by
sequence analyses. Each sequence was verified in separate
amplifications including negative controls of water be-
tween test amplifications. Multiple alignment analyses ofTable 1
Pairwise identities showing intra- and intergroup strain amino acid variation
N-terminal region 50 isolates; Italy, UK, Australia
gO genotype 1a 1b 1c
Strain group rep AD169 M TB40
AD169 98–99%
M 69–70% 98%
TB40 70% 80–81% 97%
1152B 64% 61–63% 57–59%
Can4 58% 59–60% 53–54%
ZVS 54–56% 62–63% 61–62%
Towne 51–53% 57–60% 53–56%
Full length gO sequence in seven representatives; Italian/UK/Australian isolates a
AD169 99%
M 87% 99%
TB40 86% 89% 99%
1152B 83–84% 83% 83–84%
Can4 81–82% 81% 80–81%
ZVS 77–78% 81–82% 81%
Towne 76% 79% 78%
Pairwise comparisons between N-terminal and full-length gO amino acid sequen
sequences from the N-terminal region of gO from 50 isolates (from UK, Australia
length sequence representatives of the identified seven groups compared to gO s
identities in both the N- and C-terminal regions within each genotype, where
divergence), with most amino acid substitutions in the N-terminal region, from 5the nucleotide sequences using Clustal clearly showed
seven groupings (Fig. 1). Within each group, there was
between 97% and 100% identities, while between the
seven groups, there was only 75–45% identities, thus a
marked jump in divergence of between 25% and 55%.
Only 4 isolates out of the 50 examined showed evidence
for multiple infections, in that multiple gO genotypes were
identified; these strains were not included in further
analyses, although each of these genotypes examined fell
into one of the seven groups. The reference strains AD169
and Towne fell into distinct groups as described before,
while recent isolate strain M (Minton et al., 1994) clus-
tered with the previously described recent isolate PT that
had included a notable deletion of a glycosylation site in
the C-terminal domain (Paterson et al., 2002). The endo-
thelial tropic recent laboratory strain TB40E (Sinzger et al.,
1999) also clustered in a separate group. Thus, the strains
grouped either with one of the three gO sequences we
previously described, or fell into four further groupings of
clinical isolates gO sequences. Similar analyses using
encoded amino acid sequences gave the same seven
groupings with identities within groups of 97–100% and
between groups of 51% and 81%, thus divergence of
between 19% and 49%.
Phylogenetic analyses of the gO sequences
Relationships between the groups was then further
examined using phylogenetic analyses. Given the high2a 2b 3 4
1152B Can4 ZVS Towne
97%
64–66% 98%
59% 56% 99%
54–56% 56–58% 61–62% 98–99%
nd 40 USA strains
99%
83–84% 99%
79–80% 79% 98%
79% 77% 79% 99%
ces. The first half of the table shows pairwise comparisons of amino acid
, and Italy) and laboratory strains. The second half of the table shows full-
equences from USA (Rasmussen et al., 2002). The results show 97–99%
as between groups, there ranges from 76% to 89% identities (11–24%
1% to 80% identities (20–49% divergence).
Table 3
Linkage of gO and gN genotypes, indexing with origin, disease, and sample
source
Virus strain
group rep
AD169 M TB40 1152B Can4 ZVS Towne
gO genotype 1a 1b 1c 2a 2b 3 4
gN genotype 1 3a 4c 3b 2 4a 4b
gB genotype 1,2,3 1,2,4 3 1 1,4 2 1,2
Clinical
Congenital/ 2 5 1 2 – 4 1 n = 15
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acid sequence alignments were used in the analyses as
these had increased sensitivity with more accurate align-
ments. Clustal, AMPS, and Dialign (Barton, 1994; Mor-
genstern et al., 1998; Thompson et al., 1994) were used to
generate and modify alignments, which were then
employed for phylogenetic analyses with maximum likeli-
hood, parsimony, and distance-based methods as shown
(Figs. 2A, B, C). Divergent representatives were used from
each group shown by the dendrogram output of theTable 2
Linkage of gO and gN genotypes
Strain gO-type gN-type*
AD169 1a 1
U1 1a 1
U3 1a 1
77A 1a
GR 1a 1
33B 1a 1
TD 1a 1
U6 1a 1
64A 1a 1
3E 1a 1
PT 1b
M 1b
PS 1b 3a
ML 1b 3a
12B 1b
38B 1b
15A 1b 3a
FL 1b 3a
TS 1b 3a
TB40E 1c 4c
Toledo 1c 4c
U2 1c 4c
U5 1c 4c
DM 1c 4c
A12 1c 4c
1152B 2a 3b
67A 2a
GB 2a 3b
A8 2a 3b
SNN30B 2a
Can4 2b 2
Can7 2b 2
44A 2b
ZVS 3 4a
U4 3 4a
BO 3 4a
TM 3 4a
ME 3 4a
Towne 4 4b
Davis 4 4b
V3301P2 4
1B 4 4b
309P2 4
70A 4 4b
CL452569 4
LV 4 4b
*gN-type from Pignatelli et al. (2001, 2003a, 2003b, 2003c).
newborn (C) (33%) (27%)
Transplant (T) 8
(57%)
1 2 – 2 1 – n = 14
HIV (H) 1 2 1 1 1 – 2 n = 8
Total clinical 11
(30%)
8
(22%)
4 3 3 5 3 n = 37
Majority
clinical
73%T 63%C 50%T 67%C 67%T 80%C 67%H
Distribution isolates
Italy gO 7 6 4 2 2 5 2 n = 28
Australia gO 4 3 – 2 1 – 3 n = 13
UK gO 1 2 1 2 – – 3 n = 9
Total of this
study gO
12 11 5 6 3 5 8 n = 50
*gO-USA 9 8 2 4 8 7 3 n = 41
Overall gO 21
(23%)
19
(21%)
7 10 11 12 11 n = 91
Sample source
Urine 2 5 2 2 3 2 3 n = 19
Blood 4 – 2 – – 1 1 n = 8
Saliva – 1 – – – 2 – n = 3
Lung 3 1 – 1 – – – n = 5
The upper panel shows the gO and gN linkage compared to unrelated gB
genotypes. The next panel shows distribution of gO genotypes related to
clinical information where available (n = 36). In each clinical setting, the
percentages indicate the major genotypes identified. In the final line, the
percentages indicate for each genotype the major clinical setting.
Abbreviations: T, transplantation patient isolate; C, congenital or newborn
infection isolate; H, isolate from HIV/AIDS patient; rep, strain representa-
tive of a gO genotype. The following panel examines geographic
distribution for all isolates in this study (n = 50) and adds to the reanalyzed
data from the *USA cohort (Rasmussen et al., 2002) to look at overall
distribution of total isolates examined (n = 91). The final panel examines the
sample source where information is available (n = 19) in relation to
genotypes.multiple alignment in Fig. 1. Importantly, the seven groups
were again identified by all methods. The parsimony and
maximum likelihood methods suggest a supergrouping of
four variants, but when distance methods are taken into
account, as indicated by the maximum likelihood values
and the relative presentation by protdist (Figs. 2A, C),
these clearly divide into the seven groups. Closest relation-
ships can be seen between strain groups represented by
AD169, M, and TB40E.
Given the tight clustering within groups as shown in
Figs. 1 and 2C, seven representative full-length gO
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Towne gO were resequenced as controls, together with
representatives of the other five groups: M, TB40E, ZVS,
Can4, and 1152B. Phylogenetic analyses of these full-
length sequences gave essentially similar relationships to
that of the N-terminal domains in both phylogenies deter-
mined from nucleotide and amino acid sequence align-
ments. The main difference between the N-terminal and
full-length analyses was that in the distance method; the
N-terminal analyses had higher relative distance values
(Fig. 2D). These seven groups identified from Italy,
Australia, and UK isolates also grouped with sequences
from USA isolates from a study recently published (Ras-
mussen et al., 2003). Comparisons with these sequences
using the distance method also show that they fall into the
seven groups. There is one outlier to that study (strain
3052) that might form a separate grouping if more isolates
are identified. The rest tightly cluster with the seven
groups identified here (Fig. 2D).
Interestingly, the TB40E group that includes recently
isolated laboratory strain Toledo shows a slightly different
relationship in the full-length compared to N-terminal se-
quence analyses. The TB40E group’s ancestral node moves
closer to the 1152B group on analysis of full-length gO
sequences, possibly indicating some recombination occur-
ring in the C-terminal domain. The USA study designated
four supergroups, gO1, 2, 3, and 4, but if the distancemethods
used here are taken into account, the distinct seven groups are
revealed. This is also more clearly shown in pairwise matrix
analyses in Table 1, which identify the seven divergent
groups in both the N-terminal and full-length sequences.
Representative strains are indicated by AD169, M, TB40E,
1152B, Can4, ZVS, and Towne. Within groupings, there are
only up to 2% divergence, whereas between the seven groups,
there are 11–24% differences if full-length gO sequences are
compared. There are distant cladistic relationships that mirror
the earlier USA four groupings (Rasmussen et al., 2002) and
are further subdivided here to follow the distinct groupings
indicated by the phylogenetic analysis and are designated 1a
(AD169), b (PT, M), c (Toledo), groups 2a (1152B) and 2b
(Can4), although 3 (ZVS) and 4 (Towne) remain unchanged
(Table 1 and Fig. 2D).
Glycoprotein gO and gN linkage
Isolates from the Italian cohort had been previously
genotyped for gN and gB genotypes as described (Pigna-
telli et al., 2001, 2003a). These studies had shown that
there was no correlation between these genotypes. Similar
results were found for the UK and Australian isolates.
Unlike the lack of correlation between gN and gB, there
was consistent correlation between the seven gN and gO
genotypes as noted in Tables 2 and 3, despite the high
variation at both loci.
Intriguingly, the star phylogeny for both sets of genotypes
are not duplicated, as summarized by the numbering systemsfor each genotype that reflects this order. Thus, although
g01a correlates with gN1, gO1b and 1c pair with gN 3a and
4c. Likewise, although gO2b and gO4 correlates with gN2
and gN4b, respectively, gO2a and gO3 pair with gN3b and
gN4a. The gN genotypes have been identified worldwide
(Pignatelli et al., 2001, 2003a), and all are represented in this
study. Out of the 50 isolates and laboratory strains (AD169,
Towne) examined, all seven gN genotypes described link
with the seven gO genotypes determined here as shown in
Table 3. There were four isolates with evidence for mixed
infections and multiple gO genotypes that were excluded
from the analysis. Furthermore, there were two strains that
did not fit the seven matched groupings, strains MS and 14B,
which had gO2b/gN4a and gO2a/gN4c. However, these may
also have been mixed infections as PCR using strain-specific
primers to amplify across the respective gN and gO genes
were negative. In the rare grouping, gO2b/gN2, with only
four isolates and one possible mixed infection, the generality
of this linkage is uncertain; however, all other six groups
appear to correlate between gO and gN genotypes leaving
only this linkage group that is supported by the isolates
described.
Thus, overall, these data suggest a rule for combining
gN/gO genotypes as follows with group representatives and
laboratory strains as indicated: gO1a/gN1 (AD169), gO1b/
gN3a (M, PT), gO1c/gN4c (TB40E, Toledo), gO2a/gN3b
(1152B), gO2b/gN2 (Can4), gO3/gN4a (ZVS), gO4/gN4b
(Towne).
Assessing gO genotypes disease relationships and cellular
tropism
Diseases associated with the CMV infections for the
respective isolates have been previously noted and are
tabulated here for the 37 of the isolates where information
was recorded as shown in Table 3 (Pignatelli et al., 2001,
2003a). With these numbers, it is difficult to note any trends,
except quite obviously that where supergroupings were
made for previous analyses, for example, gO for group 1
(a, b, c), or group 4 for gN (a, b, c), this would have clearly
had the affect of jumbling the gO/gN paired groups. Thus, if
there were any disease association with these hypervariable
sites, they would have been masked. Looking at this new
seven groupings of gO/gN paired linked loci, only group 1
shows a trend for linkage with transplantation disease, and
interestingly, this would be the only gO/gN pair that would
not have been previously mixed. Whether the trend for
gO1b/gN3a for associations with congenital/newborn infec-
tions is maintained would require further study. To examine
prevalence of the gO genotypes, results from this study are
taken together with those from the USA cohort, 91 total,
with 50 strains from this study and 41 isolates from the USA
study (Table 3). There seems to be no major differences in
representations of the seven gO groups between the Italian
and USA populations studied, although the Australian and
UK isolates numbers are too low to comment. Overall, the
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predominate.
As for sample source indicating possible in vivo cellular
tropisms, where details are known, they have also been
tabulated for a total of 35 isolates (Table 3). Notably,
isolates from all seven gO genotypes can be recovered from
urine, although the numbers are too low to conclude from
the other sample sites. To examine in vitro cellular tropism,
the gO sequence was also determined from strain Towne
adapted to grow either on human fibroblast or endothelial
cells (Gerna et al., 2002). These sequences were identical to
each other and to our previously reported Towne sequence
(Paterson et al., 2002), although there was a single nucle-
otide in both non-coding different to the reported USA
Towne sequence (Rasmussen et al., 2002). This suggests
that at least for this gO4 grouping, gO genotype does not
directly affect endothelial growth.
Amino acid sequence alignment analyses
Alignment of the gO genotypes was analyzed further
(Fig. 3). Given the tight conservation within each of the
seven gO genotype groups, only representatives of the seven
gO genotypes are shown. In addition, isolate 3052 from the
USA study is included. This was not used in the groupings
as it was a single finding that has not yet been recorded
elsewhere. However, for the purpose of the alignment, it
was included here. For our previous analyses of Towne,
AD169, and PT (M group), the N-terminal domain was
hypervariable, and this is clearly shown here in the phylo-
genetic analyses. Even the more closely related clades
gO1a, b, c show marked differences. We had also previously
noted the deletion of a conserved glycosylation site in the C-
terminal domain of strain PT, here designated within geno-
type gO1b (Paterson et al., 2002). It is striking that this is
also seen in the monocytic isolate M analyzed here. Fur-
thermore, from the USA sequences regrouped here, eight
fall into gO genotype 1b, and these all significantly have
this glycosylation site deleted and set this group apart from
its nearest neighbor gO1a (AD169). The gO1c (TB40E,
Toledo) genotype is also clearly set apart from the gO1a
group not only by the divergence at the N-terminus, but also
by evidence for recombination with either genotypes gO3 or
4. This is shown in Fig. 3 with a cross-marking the region in
the C-terminal domain for recombination. This explains the
difference in the phylogenies generated between the N-Fig. 3. Multiple alignment of amino acid gO sequences representative of each g
length representatives of the seven gO genotypes. Sites discussed in the text are u
signal sequence cleavage. The ‘ + ’ marks the end of the hypervariable N-term
represent regions of biased sequence content identified by SAPS and Prosite pr
highlights a triplet amino acid sequence encoded by nine nucleotides deleted in
linked glycosylation conserved in all the other groups. The ‘ + ’ sign in front of T
as noted in the text, now grouping with gO2, 3, and 4. The asterisks mark sites
discussed in the text.terminal and full-length sequences for the gO1c genotypes
(Figs. 2C, D).
Despite the divergence, all the gO sequences maintain
several characteristics. There are multiple sites for N- and
O-linked glycosylation in all the genotypes, many are
conserved, as well as numerous phosphorylation sites.
Further statistical and motif analyses of the sequence
identify a likely central surface-exposed site with a con-
served positively charged region followed by a threonine-
rich domain that includes conserved N-linked glycosyla-
tion sites and possible O-linked sites as underlined in Fig.
3 (using SAPS and Prosite motif searches) (Brendel et al.,
1992; Falquet et al., 2002). The length of each genotype
is conserved and nearly diagnostic for all sequence ana-
lyzed, as follows with reference strain for each genotype
indicated: ZVS (gO3) 1395 bp, TB40E (gO1c) 1387, M
(gO1b) 1392, 1152 B (gO2a) 1389, Towne (gO4) 1374,
Can 4 (gO2b) 1398, AD169 (gO1a) 1401. This again
highlights the strong conservation within genotypes de-
spite the diversity between genotypes.
All genotypes appear to have a similar N-terminal
signal cleavage site (between INC-KV motif on AD169,
giving a cleaved signal sequence of 30 amino acids) as
indicated in Fig. 3, as predicted using neural networks and
hidden Markov models in SignalP v2.0, 2003 (Nielsen et
al., 1999). Although in some strains other sites can also
be predicted, they are near or adjacent to this position.
From the multiple alignment, the majority of the changes
in the signal sequence are conservative maintaining hy-
drophobicity, while the N-terminus exposed after cleavage
is the most divergent on the molecule. Given this diver-
sity, the gene, and this N-terminal encoded region in
particular, was further examined for evidence of positive
selection pressure.
Maximum likelihood models of evolution and evidence for
positive selection
Previous analyses of gN had shown that this hyper-
variable glycoprotein had evidence of positive selection
(Pignatelli et al., 2003a). That study had used analyses of
an excess of nonsynonymous (dN) to synonymous differ-
ences (dS and dN/dS ratio) as an indicator for positive
selection. Since that protein appears highly conserved with-
in genotypes, there may be constraining evolution that may
mask selection of key sites, even in regions of diversityenotype. Multiple alignments of amino acid sequences encoded from full-
nderlined and highlighted with a mark. The ‘X’ marks a predicted site for
inal region used in the phylogeny analyses. The underlined sequences
ograms as discussed in the text. The SNK triplet underlined and marked
members of the gO1b (M) group that leads to the deletion of a site for N-
B40/E, gO1c, in the C-terminal region shows evidence for recombination
of positive selection in the N-terminal region as analyzed in Table 4 and
Table 4
Evidence for positive selection using maximum likelihood models of
evolution
Model code p S Estimates of
parameters
Positively
selected sites
M0 (one-ratio) 13  5938.72 x = 0.286 none
M1 (neutral) 13  5767.70 p0 = 0.572
( p1 = 0.428)
none allowed
M2 (selection) 15  5743.08 p0 = 0.390,
p1 = 0.280
( p2 = 0.330),
x2 = 0.133
none
M3 (discrete) 17  5716.18 p0 = 0.662,
p1 = 0.304
( p2 = 0.034),
x0 = 0.039,
x1 = 0.885,
x2 = 8.840
36 A, 38 Y, 39 N,
41 P, 43 R, 69 T,
93 Q
M0 (one-ratio) 13  3914.23 x = 0.201 none
M1 (neutral) 13  3853.20 p0 = 0.670
( p1 = 0.330)
none allowed
M2 (selection) 15  3842.93 p0 = 0.528,
p1 = 0.195
( p2 = 0.277),
x2 = 0.190
none
M3 (discrete) 17  3840.13 p0 = 0.729,
p1 = 0.268
( p2 = 0.003),
x0 = 0.029,
.x1 = 0.783,
x2 = 7.959
93 Q
M0 (one-ratio) 5  2980.42 x = 0.259 none
M1 (neutral) 5  2951.13 p0 = 0.702
( p1 = 298)
none allowed
M2 (selection) 7  2944.72 p0 = 0.693,
p1 = 0.291
( p2 = 0.016),
x2 = 98.994
38Y
M3 (discrete) 9  2944.24 p0 = 0.852,
p1 = 0.135
( p2 = 0.013),
x0 = 0.086,
.x1 = 1.827,
x2 = 98.993
6 M, 36 A, 38 Y,
39 N, 43 R, 45 L,
69 T
Upper panel shows results comparing the complete nucleotide sequence
from representatives of the seven gO genotypes, residue positions are
marked with reference to strain AD169 (see alignments of encoded amino
acid sequences in Fig 3). Model 3 is the best fit and shows sites under
selection in the N-terminal region (only sites with greater than 99%
probability of being under selection are shown). The middle panel shows
results for conserved C-terminal domain excluding nucleotide sequences
encoding the first 90 amino acid residues as aligned with AD169. Only one
site is shown under selection, and this is in the variable N-terminal region.
The lower panel shows results for comparisons between the most closely
related clade including gO1a, gO1b, and gO1c genotypes as represented by
AD169, TB40, and M or PT strains. Only one site in the N-terminal region
is recorded as being under selection with model 2; however, many more
sites show evidence of selection with model 3. These are all in the N-
terminal region.
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over time. Accordingly, selection was not observed when
analyzing the entire gene, but only in domains of selectedgenotypes. In order to address this issue in gO, maximum
likelihood models of evolution were used to identify indi-
vidual residues under positive selection.
An excess of nonsynonymous (dN) to synonymous (dS)
differences amongst alleles is an important indicator of
positive selection. However, signatures of selection on
essential sites may be lost where there is a background of
sites under constraining or neutral evolution. Nielsen and
Yang (1998) attempt to overcome this by using codon-based
maximum likelihood models for the evolution of protein
coding regions to estimate dN/dS (x); additional models
were also tested later (Yang and Bielawski, 2000; Yang et
al., 2000). To this end, a maximum likelihood-based anal-
ysis was performed using the codeml program and several
models as described by Yang (1997, 2002), Yang and
Bielawski (2000), and Yang et al. (2000). The seven aligned
sequences produced a single phylogeny using a maximum
likelihood search that was used with the following models
of sequence evolution in the PAML package: M0 (one-
ratio), M1 (neutral), M2 (selection), M3(discrete). Table 4
shows the Log Likelihood value of each model with the
data. These data show that the M0 (one-ratio), M1 (neutral),
and M2 (selection) models are clearly rejected in favor of
the M3 (discrete) model. The difference in Log Likelihood
values from models M3 and M2 was highly significant
(2  difference in Log Likelihood = 53.8; P < 0.001), and
numerous sites have dN/dS ratios greater than one (x2 =
8.840). All these sites represent codons located in the N-
terminal hypervariable region of the protein (Fig. 3). A
repeat analysis using the more conserved C-terminal region
of the protein produced no evidence for diversifying selec-
tion (Table 4). In this analysis, the Log Likelihood value for
model M3 was not significantly greater than that of model
M2 (2  difference in Log Likelihood = 5.6; P > 0.05), and
in addition, with model M2, no sites had dN/dS ratios greater
than one (x2 = 0.190). When the most closely related clades
of gO, 1a, 1b, and 1c, represented by TB40E, AD169, and
PT/M sequences, were analyzed on their own, models M0
and M1 were rejected in favor of model M2, which identified
a single site (38Y) as being under selection. Multiple sites
(all located in the N-terminal hypervariable region) were also
identified as being under selection with model M3, although
the difference in Log Likelihood values between models M3
and M2 was not significant.
When the branch lengths were allowed to vary in model
M0 with all seven full-length sequences, no evidence of
positive selection was seen when averaging across all sites
within the gene. When the analysis was rerun to include
only the most variable 90 N-terminal amino acid sites in the
alignment, two branches near the origin of the phylogeny
had dN/dS values greater than one (Fig. 4). One branch led
to the ancestral sequences node of the gO1a, b, c clades
represented by TB40E, AD169, and PT/M sequences and
the other to the ancestral sequences node of the gO 2a, 2b
clades represented by 1152 B and Can4 sequences. It was
thought that the gaps at the N-terminal sequence in align-
Fig. 4. Model 0 with free branch lengths shows selection for ancestral sequences. Branch lengths were allowed to vary. This is a significantly better fit than the
model 0 with x averaged across branches. The whole sequence data show no evidence for positive selection; however, when only the N-terminal sequence data
is used, the branches marked with an asterisk show evidence of positive selection (dN > dS). Removal of Towne does not affect the analysis; node numbers are
marked on the phylogeny shown.
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ancestral nodes for the gO3 and 4 clades represented by
ZVS and Towne sequences. Therefore, the analyses were
repeated without Towne with the same results.Discussion
The results of these studies of 50 strains of HCMV,
including laboratory strains and clinical isolates from di-
verse geographical locations and different disease back-
grounds, have identified seven genotypes of gO that can
be classified broadly into four clades. These consist of
gO1(a, b, c), gO2(a, b), gO3, and gO4. Comparisons
between the genotypes showed a hypervariable gene con-
sistent with our earlier studies of comparisons of AD169
sequence with laboratory strain Towne and clinical isolate
PT (Paterson et al., 2002). The most variable domain was
located at the encoded N-terminal end and showed between
25% and 55% diversity in amino acid sequence alignments.
In contrast, comparisons within genotypes showed high
conservation with only up to 1–2% variation across the
gene and no difference in diversity between the N-terminaland C-terminal domains. The clades agree with a recent
study of gO genotypes in a USA study of HIV positive and
negative transplant patients (Rasmussen et al., 2002). Inter-
estingly, the same clades are present even though the
isolates studied here are from diverse geographic locations
comprising Italy, UK, and Australia and include a wider
range of disease backgrounds, importantly including con-
genital and childhood infections.
In the USA study, genetic linkage was investigated
between gO and the other two genes encoding components
of the gCIII complex, glycoproteins gH and gL (Rasmussen
et al., 2002). Although gH and gL are conserved genes in
comparison to gO, subgroupings can still be made. When
these were compared to the variant gO genotypes, little
evidence for linkage to gH or gL was obtained, even though
gH, UL75, is encoded adjacent and upstream of gO, UL74,
while gL, UL115, is well separated. There was one favored
association with gO1 (here 1a, b, c) with gH1, but this was
not observed in all cases and there was no linkage with the
other gO genotypes (Rasmussen et al., 2002). In contrast,
studies here show that the hypervariable gN gene, UL73,
which is encoded adjacent and downstream to gO, does
appear to be linked to the gO genotypes. All seven gN
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seven gN genotypes have also been classified by phylogeny
studies into four broad clades: gN1, gN2, gN3 (a, b), and
gN4 (a, b, c). Although the individual gN genotypes link
with the individual gO genotypes, the four broad clades do
not match. This could be indicative of recombination
between the genes or different selective pressures. The
matched gN/gO partners with indicated representative
strains are gN1/gO1a (AD169), gN2/gO2b (Can4), gN3a/
gO1b (M, PT), gN3b/gO2a (1152B), gN4a/gO3 (ZVS),
gN4b/gO4 (Towne), gN4c/gO1c (TB40E, Toledo). It is
possible that with a larger collection of strains, some
recombination between these gN/gO groupings may be
observed, and it is just limited here as the genes are
adjacent. However, gH is also adjacent to gO on the 5V
end, and no linkage has been observed, although there is a
lower variation here (Rasmussen et al., 2002).
Thus, if disease relationships or functional interactions
are to be investigated, it would be important to study these
seven linkage groups rather then the broad four clades of gN
or gO that do not match and would confound the study.
Previous studies on some of the isolates examined here have
shown that the gN genotypes do not match gB genotypes
(Pignatelli et al., 2001, 2003a), and this observation also
extends to gO characterized here. However, like gH and gL,
gB is relatively conserved compared to gN and gO, and
therefore may not form linkage groups.
Further analyses of gN clades were directed at identify-
ing disease relationships. As noted above by the gN/gO
linkage, if the correct genotype grouping is not examined,
this may confound the results. Moreover, if subgroups are
made with low variation, this could also artificially con-
found the analyses. For example, Rasmussen et al. (2003),
using previously identified genotype groupings of gB and
other genes together with gO, gH, and gL, investigated
disease relationships and found a mosaic of results. If the
broad clades of gN were used to investigate disease relation-
ships, only the first category, gN1, would have correctly had
the hypervariable gO partner, gO1a, the rest would have
been mismatched. Interestingly, only this group, gN1
(gO1a), has showed initial evidence for a disease relation-
ship in HIV/AIDS patients and intrauterine infections
(Pignatelli et al., 2003b, 2003c). The gN1 (AD169 group)
clade was observed more prevalent in HIV/AIDS patients
and in congenital infections associated with a favorable
outcome. This indicates a possible less virulent grouping,
although obviously, many other determinants may contrib-
ute. Clearly, it is important from the studies shown here to
examine disease relationships with the seven genotype gN/
gO groupings identified here as the four gN superclades
used previously in analyses that would mix up and mask the
groupings with the seven gO genotypes. While not powered
for analyses of virus genotype and disease, when all the data
presented here is compiled for the newly identified seven
gN/gO genotypes together with disease background, some
interesting trends are now suggested (from Table 3). ThegN1/gO1a group is well represented in transplant patients,
while the gN3a/gO1b indicates more in congenital infec-
tions and would be of interest to follow up.
The possible distinctions in disease presentation are well
worth further investigation as data show the gM/gN (gCII)
and gO/gH/gL (gCIII) complexes account for major routes
of entry of the virus, eliciting neutralizing antibodies (with
some evidence for strain specificity to gCIII antibodies)
and roles for gCIII in fusion (Gretch et al., 1988; Hobom
et al., 2000; Huber and Compton, 1997, 1998; Li et al.,
1997; Mach et al., 2000; Paterson et al., 2002; Urban et al.,
1992, 1996), while studies of gM/gN homologues also
suggest roles in fusion, specifically fusion inhibition, as
well as egress and assembly (Brack et al., 1999; Klupp et
al., 2000; Koyano et al., 2003; Lake and Hutt-Fletcher,
2000). The genetic linkage between gN and gO implies a
functional interaction, possibly linking the virus entry and
exit mechanisms controlling fusogenic spread. Both com-
plexes have hypervariable (gN, gO) as well as relatively
conserved partners (gM, gH/gL) in the complex. The
hypervariable components may also direct specific cellular
processing and functional conformations that are being
further investigated.
What characteristics of the gO genotypes are the same and
what are different, giving indication of functional differ-
ences? All seven genotypes have the general character
described in previous reports (Huber and Compton, 1998),
encoding highly glycosylated secreted proteins with multiple
sites for N- and O-linked glycosylation. Although multiple
signal sequence cleavage sites can be predicted, all can
utilize a common site, thus releasing a hypervariable N-
terminus of gO, and recent studies have demonstrated signal
sequence cleavage in gO (Theiler and Compton, 2001). The
variable N-terminus could account for different receptor
specificities, as demonstrated by the third component of
gH/gL complexes in EBV that can bind class II molecules
and direct tropism for B cells, or epithelial cells in its absence
(Borza and Hutt-Fletcher, 2002). A similar model may
emerge for HHV-6 where a trimolecular gH/gL complex
directs binding to CD46, where the third component is
glycoprotein gQ and its homologue in the closely related
HHV-7 binds heparin (Mori et al., 2003; Santoro et al., 2003;
Skrincosky et al., 2000). Although the gO differences could
contribute to tropism differences, there is no direct evidence
that this contributes to endothelial or fibroblast tropism
differences mapping to the 15 kb deleted in strain AD169
(Cha et al., 1996). In non-plaque purified stocks of strain
Towne that were adapted to grow in either fibroblast or
endothelial cells (Gerna et al., 2002), we showed that the gO
sequence was identical. Analyses of origin of sample mate-
rial also show all genotypes secreted in urine; there may be
differences in presentation in other tissue, but the sample size
was not large enough to determine.
There are specific deletions in some of the genotypes.
This is particularly striking in the gO1b genotype that
includes strains M and PT (Minton et al., 1994; Paterson
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N-linked glycosylation site. Interestingly, in vivo studies of
HIV immune escape have recently shown that the loss of
glycosylation sites can generate marked antigenic differ-
ences and result in resistance to neutralizing antibodies (Wei
et al., 2003). However, as noted below, for the HCMV gO
genotypes, this is likely to have occurred over a much
longer time frame then fixed in the population as compared
to HIV where these changes are occurring in individual
patients. Strain PT does show resistance to gH antibodies
inhibition of cell to cell fusion, and the main coding differ-
ences are in gO of the gCIII gH/gL/gO complex (Paterson et
al., 2002). Whether this is a feature of this entire group is
under further study. Recent observations show intratuterine
infection in the presence of preconceptual immunity in the
mother (Boppana et al., 2001), and different antibody
responses to these diverse gO groups may be an important
risk factor here.
Studies on hypervariable gN have identified domains
under positive selection. This was most striking in compar-
isons of clades 3 and 4 (Pignatelli et al., 2003a). The driving
force could be from immune selection or other functional or
virulence selective pressures. However, like gO, although
there is high inter-genotypic variation, within each of the
seven genotypes there is strong conservation, so possibly
many of these changes have been fixed and under purifying
selection over time. For example, even the gene lengths are
diagnostic of and maintained within genotypes; furthermore,
some strains are almost identical between the USA and
Italian samples (see Table 1). Furthermore, TB40E, an
endothelial adapted isolate from Germany, shows complete
sequence identity (Sinzger et al., 1999) in comparisons here
with a transplant patient isolate, SW1324, from USA
reported separately (Rasmussen et al., 2002). Since gO
appears to link with gN genotypes, it was important to
determine whether gO is also under positive selection
possibly driven by functional interactions. As the individual
genotypes seem fixed, they may have accumulated many
synonymous mutations, masking evidence of positive se-
lection despite the high diversity. In order to investigate this
further, maximum likelihood models were used to analyze
codon effects of Darwinian evolution as measured by
analyses of ratios of nonsynonymous coding versus synon-
ymous non-coding substitutions.
The maximum likelihood models are a potentially pow-
erful new method for detecting selection in individual
codons (Yang, 2002; Yang and Bielawski, 2000; Yang et
al., 2000). They are applied here for the first time to analysis
of the type of variation observed in persistent infections
from the ancient herpesvirus group. Multiple nonsynony-
mous mutations are evident throughout the full sequence
data from the seven divergent isolates analyzed here;
however, the level of synonymous mutations between the
sequences results in a dN/dS ratio (x) of less than one,
showing no evidence for selection, when using the older
method of Nei and Gojobori (1986). The use of codon-basedmodels by contrast has identified here multiple codons
within the region encoding the highly divergent 100 N-
terminal amino acids as being under positive Darwinian
selection, despite an overall dN/dS ratio of 0.42 for this
region. These sites are at the N-terminal end adjacent to the
signal sequence cleavage predicted site. Due to the high
diversity here, some alignments may be confounded; there-
fore, analyses were repeated within the more closely related
clade 1. When the three more conserved sequences within
clade 1 (gO1a, b, c represented by TB40E, AD169, M, and
PT sequences) are considered, the evidence for selection is
much weaker and only a single site with an x value of
greater than one, thus showing positive selection, is robustly
identified, although this does overlap with sites identified
comparing representatives of all seven groups. Given the
lack of evidence for strong positive selection within these
closer related sequences, it is possible that sites in the N-
terminal domain are no longer under diversifying selection.
Furthermore, there seems to be no geographic effect as
similar results were obtained using the USA and Italian
sample collections. It is doubtful therefore that epitopes
within these sequences are currently under immune selective
pressure, for example, which is likely to have contributed to
the diversification of cytotoxic T-lymphocyte (CTL) epito-
pes in simian immunodeficiency virus (Evans et al., 1999)
and human immunodeficiency virus 1 (Borrow and Shaw,
1998; Lopes et al., 2003; Yang et al., 2000).
All the above results were produced by averaging dN/dS
ratios across branch lengths in the phylogeny (i.e., the dN/
dS ratio was the same for each branch of the phylogeny).
When branch lengths were allowed to vary, but dN/dS ratios
averaged across all sites in the full-length sequences (using
model M0), there was no evidence of a sudden burst of
positive selection in any branches of the phylogeny. How-
ever, when the analysis was repeated with the N-terminal 90
amino acids, two branches near the origin had dN/dS ratios
much greater than one. These were ancestral sequences
leading to clades 1 and 2 (represented by clade 1: AD169,
TB40E, M, PT, and clade 2: 1152B, and Can4). It is
possible, therefore, that nonsynonymous mutations within
the N-terminal amino acids were positively selected early in
the evolution of the HCMV gO gene. Should any positive
selection be followed by a long period of purifying selec-
tion, any fixation of synonymous changes within different
lineages of HCMV could produce dN/dS ratios of less than
one, both for the sequence as a whole and possibly for
individual codons under selection. Thus, additional sites,
not identified by this study, may also have been subjected to
diversifying selection. Identification of further genotypes
may change the analyses, for example, an additional geno-
type is suggested in the USA study, but this has yet to be
confirmed with other isolates.
Genomic rearrangements may have contributed to the
early burst of evolution followed by purifying selection.
Some evidence for early recombination are shown in the
gO1b genotype represented by TB40E. Here the C-terminal
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and gO4, shown in alignments and by phylogeny studies
comparing N-terminal and full-length sequences. This is
now fixed and under purifying selection. Thus, in Clade 1
main diversifying features include glycosylation deletion in
1b and C-terminal exchange in 1c. Whether the matching of
the gN/gO genotypes across their respective supergroups is
also evidence for recombination is an interesting question.
The position between the gN and gO genes is a major site
for rearrangement between herpesvirus lineages (Gompels
et al., 1995), and the gN/gO relationship may be an echo of
this event that has contributed to the biology of entry and
exit of this h herpesvirus subgroup.Materials and methods
Patients isolates and laboratory strains
Isolates from Italy have been described (Pignatelli et al.,
2001, 2003a). Briefly, isolates TM, ME, ZVS, LV, A8, GR,
FL, TS were from congenital infections; BO, ML, PS, DM,
VL were from newborn or child infections; U4, Can7, U2
from Kidney transplant infections; Can4, U1, U7, U3 from
heart transplant infections; U6, U5 from liver transplant
infections; FC, A12 from HIV patients; MS, GB, TD, HDS,
RC not specified. Isolates from Australia include 1B, 77A
from bone marrow transplant patients; 64A from a heart
transplant patient; Cl452569, 67A, 44A, 3E, 38B, 12B from
HIV patients; 14B, 33B from congenital infection; 15A,
70A not specified. Isolates from UK include 309P2,
V33001P2, 1152B, SNN30B. Isolates were not passaged
but obtained from supernatants derived from their initial
isolation on human embryonic lung fibroblasts (HELF)
(urine or saliva samples) or amplified directly from DNA
extracted from biopsy or tissue samples. Also included are
laboratory strains AD169 and Towne; low passage clinical
isolate PT (Paterson et al., 2002); endothelial strain TB40E,
from a bone marrow transplant patient (Sinzger et al., 1999);
monocytic strain M, Meakin, from a lung biopsy from a
heart– lung transplant patient (Minton et al., 1994) (TB40
and M kindly donated, respectively, by G. Jahn, University
of Tubingen, Germany, and J. Sinclair, University of Cam-
bridge, UK); human umbilical vein endothelial cells
(HUVEC) or HELF cell adapted strains of Towne (Gerna
et al., 2002) (generously provided by G. Gerna, University
of Pavia, Italy).
DNA extractions, polymerase chain reaction amplifications,
and DNA sequencing
DNAwas extracted from isolates as described (Pignatelli
et al., 2001, 2003a) and used in PCR reactions as noted
below with specific gO oligonucleotide forward and reverse
primer pairs. Alternatively, amplifications were performed
using the isolate infected cell supernatant directly. PCR wasconducted in 30-Al reactions containing 200 AM of each
dNTP, 1.5U of 1 Taq DNA polymerase (Promega; storage
buffer B) in 1 Taq reaction buffer (Promega), 250 ng of
each primer, and 1.5 mM MgCl2. In order to amplify the N-
terminal domain of gO (450 bp), the following oligonucle-
otide primer pair was used; their positions relative to the
first gO base from AD169 noted in parenthesis: GO1 (10)
5 VCTCCTCTGTCATGGGGAGAAA3 V, GO2 (+459)
5VAGAAAGACAAGTCATGGAAGG3V. Additional PCR or
sequencing primers used instead of GO2 were GOR2
(+1189) 5VGGAAGCCGTTTCGTTTTCCAC3V, GO2A
(+470) 5VAGATAGACAGCCCATAGATGG3V or GO2B
5VGGATAAACAATTCATAGAAGG3V. Full-length gO se-
quence (between 1388 and 1395 bp) was amplified and
sequenced from seven strains (ZVS, Can4, 1152B, TB40E,
M, HUVEC Towne, and HELF Towne). In addition to the
above primer pairs, the following nested primer pairs (also
used for sequencing) GOF3/GOR3, GOF2/GOR3, F27/
GOR3, GO1/GOR3, and additional internal sequencing
p r imer GOR3B were used : GOF3 (+1054) 5 V
ACCGCCGTATCAGAATTTATG3 V, GOR3 (+1401)
5 VTTACTGCAACCACCACCAAAG3 V, F27 (+301)
5VGAAAGTGTAACTCATTTGTGG3V, GOR3B (+1102)
5 VGAAACACCGTACACTATTTA3 V, GOF2 (+667)
5VAGTTTTTACCTGGTTAACGCC3V. Thermal cycling
parameters were 94 jC for 4 min and 50 cycles of 94 jC
for 30 s, 45 jC for 30 s, 72 jC for 2 min, and a final
elongation at 72 jC for 5 min. PCR products were purified
using the Amicon Microcon PCR centrifugal filter devices
(Millipore) according to the manufacturer’s protocol, fol-
lowed by ethanol precipitation. DNA sequencing was per-
formed using the dideoxynucleotide chain-termination
method with fluorescent dyes (ABI Prism Big Dye Kit)
according to the manufacturer’s instructions, followed by
ethanol precipitation, then separation by electrophoresis on
an ABI377 automated sequencer (PE Applied Biosystems).
Resulting sequences as computer traces were visualized
using Chromas 1.61(Technelysium Pty). Initial alignments
against reference strains AD169 and Towne (Paterson et al.,
2002) were made using Clustal-based algorithms on Dnasis
Pro V3.5 software (Higgins and Sharp, 1988). Sequence
Genbank accession numbers are to be assigned.
Phylogenetic and coding sequences analyses
Phylogenetic analyses was performed using multiple
alignments generated by Clustal, AMPS, and Dialign (Bar-
ton, 1994; Morgenstern et al., 1998; Thompson et al., 1994)
based programs on the MAGI, Multiple Alignment General
Interface, and PIE, Phlyogeny Interface Environment, suite
of alignment and phylogeny programs at the human genome
mapping resource center (HGMP) that included maximum
likelihood, parsimony, and distance-based methods. Phylo-
genetic analyses of the amino acid sequence with the
maximum likelihood approach used the ProtMl program
(v2.2, 1994) with JTT model (Jones et al., 1992), star search
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using parsimony used the protpars program with bootstrap-
ping (100) performed by the seqboot program in PHYLIP,
phylogeny inference package (Felsenstein, 1989). Analyses
using the distance method used the protdist program (PHY-
LIP) with the PAM distance model and neighbor distance
matrix program. The Swissprot expasy suite of programs
were used to analyze coding sequences: signal sequences
were analyzed using neural network analyses and hidden
Markov models trained on eukaryote signal sequences
(SignalP, v2.0) (Nielsen et al., 1999), the Prosite database
was searched for protein motifs (Falquet et al., 2002), and
statistical analyses of amino acid sequence biases by SAPS
(Brendel et al., 1992). Positive selection was analyzed using
Dialign multiple alignments of nucleotide sequence repre-
sentatives of each clade using peptide diagonals to maintain
alignments with gaps consistent with triplet codons. This
was analyzed for ratios of non-synonymous to synonymous
changes site by site using four models with maximum
likelihood analyses by the codeml program (see below).
Selected sites of positive selection were marked on multiple
alignments formatted using Boxshade program with ASCI
output highlighting differences (v3.21).
Analysis of dN/dS ratios by maximum likelihood
A maximum likelihood-based analysis was performed
using the codeml program (part of the PAML package,
http://abacus.gene.ucl.ac.uk/software/paml.html) (Yang,
1997) to look for the presence of sites under diversifying
selection (dN/dS ratio > 1) within the HCMV gO, UL74
gene. Phylogenetic trees (generated by the above described
strain analyses) represented by TB40E, AD169 and PT,
1152B, Can4, Towne, and ZVS sequences were used in the
codem1 models (M): 0 (one-ratio), 1 (neutral), 2 (selection),
and 3 (discrete), and a formal comparison of these models
made using the likelihood ratio test (Yang and Bielawski,
2000; Yang et al., 2000). M0 assumes one dN/dS ratio (x)
for all sites; M1 assumes conserved sites with x = 0 and a
separate class of neutral sites with x = 1; M2 in addition to
M1 adds a third class of sites with x estimated from the
data; M3 models (using unconstrained discrete distribution)
heterogeneous x among sites and here uses K = 3 classes.
Codon usage was estimated from the actual codon frequen-
cies of data for the calculation of the dN/dS ratios while all
other parameters were set at the program default values. The
translated full-length alignment used for the comparison of
the seven sequences is shown in Fig. 3, nucleotide align-
ments were made using peptide diagonals to maintain triplet
codon alignments. For analysis of the C-terminal conserved
region, the first 90 amino acid residues in the alignment
(based on AD169) were excluded from the analysis. Where
the AD169, M, and TB40 sequences (gO1a, b and c) were
analyzed in isolation, the alignment of these three sequences
was identical to that shown in Fig. 3, and a star phylogeny
was used for each of the models M0 to M3.Acknowledgments
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